2-Methylbutan-2-sulfochlorid | 16489-14-8

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 磺酰卤
• 英文名称: 2-Methylbutan-2-sulfochlorid
• 英文别名: 2-Methylbutane-2-sulfonyl chloride
• CAS: 16489-14-8
• 化学式: C₅H₁₁ClO₂S
• mdl: MFCD19200188
• 分子量: 170.66
• InChiKey: SAKMQEBULSKIQM-UHFFFAOYSA-N

物化性质

• 沸点：
  207.5±9.0 °C(Predicted)
• 密度：
  1.188±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  42.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-Methylbutan-2-sulfochlorid 、 苯肼 以 乙醚 为溶剂， 生成 2-Methyl-butan-sulfonsaeure-(2)-<β-phenyl-hydrazid>
  参考文献：
  名称：

  Asinger,F. et al., Chemische Berichte, 1967, vol. 100, p. 1696 - 1700

  摘要：

  DOI：
• 作为产物：
  描述：

  2-氯代-2-甲基丁烷 生成 2-Methylbutan-2-sulfochlorid
  参考文献：
  名称：

  Asinger,F. et al., Chemische Berichte, 1967, vol. 100, p. 1696 - 1700

  摘要：

  DOI：

文献信息

• [EN] PYRIMIDINYL-PYRIDYLOXY-NAPHTHYL COMPOUNDS AND METHODS OF TREATING IRE1-RELATED DISEASES AND DISORDERS<br/>[FR] COMPOSÉS PYRIMIDINYL-PYRIDYLOXY-NAPHTYLE ET PROCÉDÉS DE TRAITEMENT DE MALADIES ET DE TROUBLES LIÉS À IRE1
  申请人：GENENTECH INC

  公开号：WO2018166528A1

  公开（公告）日：2018-09-20

  Described herein are pyrimidinyl-pyridyloxy-naphthyl compounds with inositol requiring enzyme 1 (IRE1) modulation activity or function having the Formula (I) or (I') structure : or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the Formula (I) or (I') compounds, as well as methods of using such IRE1 modulators, alone and in combination with other therapeutic agents, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.

  本文描述了具有肌醇需要酶1（IRE1）调节活性或功能的嘧啶基-吡啶氧基-萘基化合物，其具有公式（I）或（I'）结构：或其立体异构体，互变异构体或药学上可接受的盐，并具有所述的取代基和结构特征。还描述了包括公式（I）或（I'）化合物的制药组合物和药物，以及使用这种IRE1调节剂的方法，单独或与其他治疗剂联合治疗介导或依赖于雌激素受体的疾病或病况。
• [EN] NECROSIS INHIBITORS<br/>[FR] INHIBITEURS DE NÉCROSE
  申请人：NAT INST OF BIOLOG SCIENCES BEIJING

  公开号：WO2016101887A1

  公开（公告）日：2016-06-30

  The invention provides amides that inhibit cellular necrosis and/or human receptor interacting protein 1 kinase (RIP1), including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.

  该发明提供了抑制细胞坏死和/或人类受体相互作用蛋白1激酶（RIP1）的酰胺，包括相应的磺酰胺，以及其药用盐、氢化物和立体异构体。这些化合物用于制备药物组合物，并用于制备方法，包括用有效量的化合物或组合物治疗需要的人，并检测人的健康或状况的改善。
• METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF
  申请人：Kuramoto Ayako

  公开号：US20120130089A1

  公开（公告）日：2012-05-24

  The present invention is directed to provide an efficient production method which is capable of not only obtaining a cyclic sulfonic acid ester (sultone) at low cost and in high yield, but also the sulfonic acid ester (sultone) stably even in a commercial scale. The present invention relates to a method for producing hydroxysultone comprising a first step where a diol having a specified structure and a thionyl halide are reacted to obtain a cyclic sulfite having a specified structure, and a second step where the cyclic sulfite is reacted with water or/and alcohol; a method for producing an unsaturated sultone having a specified structure comprising a third step where a hydroxylsultone having a specified structure is reacted with an acid halide or an acid anhydride to obtain an intermediate, subsequently the intermediate is treated with a base; as well as a cyclic sulfite having a specified structure.

  本发明旨在提供一种高效的生产方法，该方法不仅能够以低成本和高产率获得环状磺酸酯（磺酮），而且能够在商业规模下稳定地生产磺酸酯（磺酮）。本发明涉及一种生产羟基磺酮的方法，包括第一步，其中将具有特定结构的二元醇和硫酰卤反应，以获得具有特定结构的环状亚磺酸酯，以及第二步，其中将环状亚磺酸酯与水或/和醇反应；一种生产具有特定结构的不饱和磺酮的方法，包括第三步，其中将具有特定结构的羟基磺酮与酸卤或酸酐反应，以获得中间体，随后用碱处理中间体；以及具有特定结构的环状亚磺酸酯。
• Process for the preparation of sulfonylamino benzophenones
  申请人：ELI LILLY AND COMPANY

  公开号：EP0093590A1

  公开（公告）日：1983-11-09

  A novel process is provided which roduces intermediates useful in the regiospecific synthes s of benzimidazole antiviral agents. The process comprises reacting a 3-fluoro-4-nitrobenzophenone with an anion of a sL fonamide to yield a 3-substitutedsulfonylamino-4-nitrobenzohenone. Novel intermediates are also disclosed.

  本发明提供了一种新工艺，可生产出用于苯并咪唑类抗病毒药物的区域特异性合成的中间体。该工艺包括使 3-氟-4-硝基苯甲酮与 sL 芳酰胺的阴离子反应，生成 3-取代磺酰胺基-4-硝基苯甲酮。还公开了新的中间体。
• PROCESS FOR PRODUCING ACID ANHYDRIDE
  申请人：Tokuyama Corporation

  公开号：EP1413572A1

  公开（公告）日：2004-04-28

  According to the present invention there is provided a process for producing an acid anhydride by reacting a carboxylic acid, preferably a carboxylic acid having a polymerizable group, with a sulfonyl halide compound in the presence of a tertiary amine or in the presence of a tertiary amine and an inorganic base, wherein the tertiary amine or the tertiary amine and the inorganic base are used in an amount of 0.9 to 1.2 equivalents relative to the acid generated from the sulfonyl halide compound.

  根据本发明，提供了一种生产酸酐的工艺，其方法是在叔胺存在下或在叔胺和无机碱存在下，使羧酸（最好是具有可聚合基团的羧酸）与磺酰卤化合物反应，其中叔胺或叔胺和无机碱的用量相对于磺酰卤化合物生成的酸为 0.9 至 1.2 个当量。